Dr. Stéphane Roche, PhDFounder and CEO at AdaptBio TherapeuticsSpeaker
Profile
Stéphane is the founder and CEO of AdaptBio Therapeutics (Est. in 2024). He has 15+ years of experience in synthetic and medicinal chemistry in diverse therapeutic areas, working on small-molecule natural products and peptide drugs. Stéphane is also a faculty at Florida Atlantic University, where he works on a variety of peptide drug discovery and preclinical development programs focusing on protein-protein interactions. Stéphane received a Ph.D. in Organic Chemistry from the Blaise Pascal University (France) and conducted post-doctoral studies at the @Star ICES Institute (Singapore) and at Boston University in the field of natural product total synthesis.
Agenda Sessions
ADAPT: An Emerging Platform of Antibody CDR-H3 Peptide Scaffolds in the Landscape of Protein-Protein Interaction Inhibitors
, 11:45amView Session
